RESHAPE LIFESCIENCES INC (RSLS)
US76090R2004 - Common Stock
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
Effective as of Commencement of Trading on September 23, 2024
ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
Effective as of Commencement of Trading on September 23, 2024...
RSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024
RSLS stock results show that Reshape Lifesciences missed on revenue for the second quarter of 2024.
RSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reshape Lifesciences (NASDAQ:RSLS) just reported results for the second quarter...
ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, August 15, 2024
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Thursday, August 15, 2024...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GLXZ, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, RSLS, TLRS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
ReShape and Vyome, a Clinical Stage Specialty Pharmaceutical Company Working To Treat Immuno-Inflammatory Diseases of Unmet Need, to Combine in All-Stock...
Why Is Cue Health (HLTH) Stock Down 40% Today?
Cue Health stock is down on Wednesday as HLTH investors react to the healthcare company filing for Chapter 7 bankruptcy relief.
Why Is Faraday Future (FFIE) Stock Down 32% Today?
Faraday Future stock is falling hard on Wednesday as FFIE investors aren't impressed by the company's earnings report for 2023.
Why Is Banzai International (BNZI) Stock Up 25% Today?
Banzai International stock is up Wednesday with heavy trading of BNZI shares after closing out a recent public offering.
Why Is Reshape Lifesciences (RSLS) Stock Up 80% Today?
Reshape Lifesciences stock is up on Wednesday with heavy trading of RSLS shares despite a lack of news from the company this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning!
RSLS Stock Earnings: Reshape Lifesciences Beats EPS, Misses Revenue for Q1 2024
RSLS stock results show that Reshape Lifesciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
RSLS Stock Earnings: Reshape Lifesciences Beats EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Reshape Lifesciences (NASDAQ:RSLS) just reported results for the first quarter ...